BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16043495)

  • 1. Evolvability of the mode of peptide binding by an RNA.
    Iwazaki T; Li X; Harada K
    RNA; 2005 Sep; 11(9):1364-73. PubMed ID: 16043495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
    Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
    J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring the peptide-binding specificity of an RNA by combinations of specificity-altering mutations.
    Sugaya M; Nishimura F; Katoh A; Harada K
    Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):534-45. PubMed ID: 18569791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An isostructural G-G to A-A substitution within the HIV RRE RNA switches the specificity towards arginine-rich peptides.
    Aoyama S; Sugaya M; Kobayashi C; Masuda K; Maeda T; Sakamoto T; Kawai G; Katoh A; Harada K
    Nucleic Acids Symp Ser (Oxf); 2009; (53):271-2. PubMed ID: 19749365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
    Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
    PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of the peptide-binding specificity of an RNA in a rational manner by combinations of specificity-altering mutations.
    Harada K; Sugaya M; Nishimura F; Katoh A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):13-4. PubMed ID: 18776229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variability of the peptide-binding specificity of RNA.
    Harada K; Iwazaki T; Li X; Yuda A; Kobayashi K
    Nucleic Acids Res Suppl; 2003; (3):201-2. PubMed ID: 14510450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method for detection of specific nucleic acids by recombinant protein with fluorescent resonance energy transfer.
    Endoh T; Funabashi H; Mie M; Kobatake E
    Anal Chem; 2005 Jul; 77(14):4308-14. PubMed ID: 16013840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molding a peptide into an RNA site by in vivo peptide evolution.
    Harada K; Martin SS; Tan R; Frankel AD
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient thermally induced RNA conformational switch as a framework for the functionalization of RNA nanostructures.
    Li X; Horiya S; Harada K
    J Am Chem Soc; 2006 Mar; 128(12):4035-40. PubMed ID: 16551112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of primary sequences and secondary structures of rev responsive element from HIV-1 infected mothers and infants following vertical transmission.
    Ramakrishnan R; Ahmad N
    Virology; 2007 Mar; 359(1):201-11. PubMed ID: 17045321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized codon mutagenesis reveals that the HIV Rev arginine-rich motif is robust to substitutions and that double substitution of two critical residues alters specificity.
    Possik EJ; Bou Sleiman MS; Ghattas IR; Smith CA
    J Mol Recognit; 2013 Jun; 26(6):286-96. PubMed ID: 23595810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of ribonucleopeptide aptamer against ATP.
    Mashima T; Matsugami A; Nakano S; Inoue M; Fukuda M; Morii T; Katahira M
    Nucleic Acids Symp Ser (Oxf); 2009; (53):267-8. PubMed ID: 19749363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the mechanism of peptide binding to REV response element RNA of HIV-1; MD simulations and free energy calculations.
    Ali N; Khalil R; Nur-E-Alam M; Ahmed S; Ul-Haq Z
    J Biomol Struct Dyn; 2022 Jul; 40(10):4399-4408. PubMed ID: 33323039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.